SRC and cholangiocarcinoma: Studies have shown that Src inhibition can restore the tumor suppressor function of MAGI1-PP2A, such as the S6K/AKT inhibitor M2698, suggesting the therapeutic value of Src inhibitors in mIDH CCA [120].